-
Mercados
athexgroup.grAthens Exchange GroupRead moreTogether for a unified, stronger European capital market.
-
Acções
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Índices
A milestone in a decade of transformationEuronext joins the CAC 40®Read moreAs of 22 September 2025, Euronext has officially joined the CAC 40®, France’s flagship blue-chip index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fundos
-
Obrigações
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Warrants & Certificados
-
Derivados
Where European Government Bonds Meet the FutureTrade Mini Bond FuturesRead moreTrade mini bond futures on main European government bonds
-
Matérias-Primas
- Vista global
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Dairy derivatives
- Salmon derivatives
- Container Freight Futures
- Entrega e liquidação
- Especificações e disposições
- Commitments of Traders (CoT) report
- Commodity brokers
Take control of unpredictable dairy pricesEuropean Dairy DerivativesRead moreFutures and options on butter and skimmed milk powder now trading.
-
Recursos
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 22 Feb 2024 09:24 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Invitation to presentation of Q4 2023 operational update | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jan 2024 08:45 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Recruitment completed in the phase IIb HeROPA clinical trial | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jan 2024 08:45 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - HeROPA-studien er fullrekruttert | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 15 Dec 2023 09:04 CET |
ARCTIC BIOSCIENCE AS | Finansiell kalender | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 15 Dec 2023 09:04 CET |
ARCTIC BIOSCIENCE AS | Financial calendar | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Dec 2023 08:00 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - More than 75% recruited in the phase IIb HeROPA clinical trial | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Dec 2023 08:00 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Over 75% rekruttert til den kliniske fase IIb HeROPA-studien | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 02 Nov 2023 08:00 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Q3 2023 Operational update - More than 50% recruited in the phase IIb HeROPA clinical trial | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Nov 2023 08:00 CET |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - 3. kv. 2023 oppdatering - Over 50% rekruttert til den kliniske fase IIb HeROPA-studien | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |